ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/24 | 2,965 | 2,970 | 2,917 | 2,942 | -8 | -0.3% | 263,900 |
2020/04/23 | 2,919 | 2,956 | 2,886 | 2,950 | +53 | +1.8% | 202,800 |
2020/04/22 | 2,852 | 2,912 | 2,835 | 2,897 | +39 | +1.4% | 217,200 |
2020/04/21 | 2,882 | 2,902 | 2,851 | 2,858 | -23 | -0.8% | 180,700 |
2020/04/20 | 2,900 | 2,934 | 2,830 | 2,881 | -19 | -0.7% | 182,500 |
2020/04/17 | 2,934 | 2,935 | 2,855 | 2,900 | -7 | -0.2% | 163,900 |
2020/04/16 | 2,872 | 2,915 | 2,861 | 2,907 | +55 | +1.9% | 225,100 |
2020/04/15 | 2,881 | 2,898 | 2,818 | 2,852 | -9 | -0.3% | 265,500 |
2020/04/14 | 2,855 | 2,880 | 2,847 | 2,861 | +21 | +0.7% | 159,300 |
2020/04/13 | 2,817 | 2,849 | 2,771 | 2,840 | -36 | -1.3% | 157,600 |
2020/04/10 | 2,812 | 2,889 | 2,766 | 2,876 | +62 | +2.2% | 217,900 |
2020/04/09 | 2,840 | 2,850 | 2,759 | 2,814 | -27 | -1% | 228,900 |
2020/04/08 | 2,794 | 2,866 | 2,785 | 2,841 | +59 | +2.1% | 324,700 |
2020/04/07 | 2,755 | 2,796 | 2,719 | 2,782 | +73 | +2.7% | 276,800 |
2020/04/06 | 2,693 | 2,728 | 2,648 | 2,709 | +66 | +2.5% | 276,800 |
2020/04/03 | 2,661 | 2,715 | 2,614 | 2,643 | +3 | +0.1% | 192,800 |
2020/04/02 | 2,640 | 2,697 | 2,607 | 2,640 | +15 | +0.6% | 270,300 |
2020/04/01 | 2,714 | 2,755 | 2,606 | 2,625 | -127 | -4.6% | 319,800 |
2020/03/31 | 2,822 | 2,856 | 2,738 | 2,752 | -52 | -1.9% | 392,200 |
2020/03/30 | 2,776 | 2,804 | 2,705 | 2,804 | +6 | +0.2% | 408,900 |
2020/03/27 | 2,777 | 2,798 | 2,690 | 2,798 | +71 | +2.6% | 559,700 |
2020/03/26 | 2,614 | 2,761 | 2,583 | 2,727 | +116 | +4.4% | 507,000 |
2020/03/25 | 2,694 | 2,694 | 2,582 | 2,611 | -67 | -2.5% | 541,100 |
2020/03/24 | 2,702 | 2,760 | 2,606 | 2,678 | +26 | +1% | 398,700 |
2020/03/23 | 2,655 | 2,697 | 2,550 | 2,652 | +44 | +1.7% | 559,300 |
2020/03/19 | 2,573 | 2,608 | 2,477 | 2,608 | +222 | +9.3% | 512,900 |
2020/03/18 | 2,488 | 2,548 | 2,374 | 2,386 | -52 | -2.1% | 449,200 |
2020/03/17 | 2,260 | 2,480 | 2,189 | 2,438 | +152 | +6.6% | 699,000 |
2020/03/16 | 2,404 | 2,448 | 2,283 | 2,286 | -109 | -4.6% | 553,200 |
2020/03/13 | 2,409 | 2,475 | 2,264 | 2,395 | -114 | -4.5% | 550,200 |
2020/03/12 | 2,574 | 2,589 | 2,476 | 2,509 | -115 | -4.4% | 354,900 |
2020/03/11 | 2,605 | 2,675 | 2,600 | 2,624 | +56 | +2.2% | 649,300 |
2020/03/10 | 2,498 | 2,592 | 2,403 | 2,568 | +47 | +1.9% | 338,600 |
2020/03/09 | 2,566 | 2,567 | 2,490 | 2,521 | -95 | -3.6% | 234,500 |
2020/03/06 | 2,652 | 2,660 | 2,600 | 2,616 | -67 | -2.5% | 200,800 |
2020/03/05 | 2,712 | 2,712 | 2,667 | 2,683 | +43 | +1.6% | 219,800 |
2020/03/04 | 2,599 | 2,683 | 2,594 | 2,640 | +7 | +0.3% | 369,100 |
2020/03/03 | 2,674 | 2,689 | 2,617 | 2,633 | +31 | +1.2% | 508,900 |
2020/03/02 | 2,526 | 2,615 | 2,510 | 2,602 | +86 | +3.4% | 337,300 |
2020/02/28 | 2,519 | 2,542 | 2,483 | 2,516 | -63 | -2.4% | 433,700 |
2020/02/27 | 2,615 | 2,621 | 2,568 | 2,579 | -51 | -1.9% | 280,800 |
2020/02/26 | 2,626 | 2,634 | 2,603 | 2,630 | -26 | -1% | 585,100 |
2020/02/25 | 2,688 | 2,699 | 2,650 | 2,656 | -150 | -5.3% | 420,800 |
2020/02/21 | 2,796 | 2,833 | 2,792 | 2,806 | +3 | +0.1% | 231,200 |
2020/02/20 | 2,798 | 2,819 | 2,791 | 2,803 | -11 | -0.4% | 236,900 |
2020/02/19 | 2,838 | 2,845 | 2,805 | 2,814 | +3 | +0.1% | 199,900 |
2020/02/18 | 2,861 | 2,867 | 2,811 | 2,811 | -50 | -1.7% | 202,000 |
2020/02/17 | 2,913 | 2,913 | 2,854 | 2,861 | -98 | -3.3% | 299,300 |
2020/02/14 | 2,952 | 2,964 | 2,937 | 2,959 | -3 | -0.1% | 338,900 |
2020/02/13 | 2,960 | 2,991 | 2,937 | 2,962 | -123 | -4% | 279,400 |
1251~
1300
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム